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The fifth edition of the Diagnostic and Statistical Manual
of Mental Disorders (DSM-5) has broadened the criteria
for specified bipolar disorders with the introduction of
the diagnostic category of ‘other specified bipolar and
related disorders’ (DSM-5: 296.89). In a prior editorial,
we critically discussed how the way we diagnose bipolar
disorders may impact treatment decisions, especially
for patients with newly specified subthreshold bipolar
II disorder (full depressive episode plus a hypomanic
episode that does not meet the duration or number of
symptoms required for a full episode) (Frances and
Jones 2012; Phillips and Kupfer 2013; Severus and
Bauer 2013; Zimmerman 2012; Angst 2013). In this
editorial, we will examine how treatment decisions
may, in turn, impact the diagnosis of bipolar disorders.
Specifically, we will focus on how acute and prophylactic
treatment of subthreshold bipolar II disorder may impact
the rate of conversion to a diagnosis of bipolar I disorder.
In the DSM-5, subtypes of the nonorganic bipolar disor-
ders are differentiated primarily by the number, duration,
and intensity of the manic symptoms, as summarized in
Table 1. To illustrate how the treatment of subthreshold
bipolar II disorder may impact diagnosis, we will consider
the case of a young patient with a history of a major
depressive episode who visits his psychiatrist. Starting
abruptly over the last 2 days, the patient felt increasingly
‘hyper’ and energetic despite sleeping less than usual
and had a fierce argument with his girlfriend. On close
scrutiny, it turned out that the patient's history is also
positive for a single past episode of short-duration
hypomania, but negative for hypomanic or manic episodes,
use of antidepressants, other substance use, and medical
comorbidities (Do and Mezuk 2013). However, his father
suffers from severe bipolar I disorder. The patient is
exhibiting a prototype hypomanic syndrome (DeFife
et al. 2013), meets the DSM-5 criteria for ‘short-duration* Correspondence: Emanuel.Severus@uniklinikum-dresden.de
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reproduction in any medium, provided the orighypomanic episodes (2 to 3 days) and major depressive
episodes,’ and is therefore diagnosed with ‘other specified
bipolar and related disorders.’ From a clinical perspective,
the current hypomanic syndrome may be the beginning
of a full manic episode, particularly with the positive
family history. Now consider the potential impact of three
acute treatment approaches on the future diagnosis of this
patient: (1) The psychiatrist prescribes a high dose of a
fast-acting drug approved for the acute treatment of
manic episodes, such as an atypical antipsychotic, with the
possibility of further dose escalation. With this medication
regimen, the hypomanic syndrome will probably decrease
within a short period of time. Two days later, the patient
may no longer meet the full criteria for a hypomanic
episode and the diagnosis of ‘other specified bipolar
and related disorders’ will remain. (2) The psychiatrist
prescribes a lower dose of the same atypical antipsychotic.
In this case, the patient may still meet the criteria for a
hypomanic episode 2 days later and will be diagnosed
with bipolar II disorder. (3) The psychiatrist decides on
watchful waiting and prescribes only a mild hypnotic.
The patient will develop a manic episode and will be
diagnosed with bipolar I disorder.
Similarly, long-term treatment may impact the diagnosis.
Assume the patient in this example develops a hypomanic
episode and is diagnosed with bipolar II disorder. Once
remission is achieved, given the recent episode and family
history of bipolar I disorder, prophylactic antimanic treat-
ment is recommended in recent guidelines (Pfennig et al.
2012). The intensity of this prophylactic treatment (low to
moderate dose of an atypical antipsychotic or, if further
hypomanic episodes occur, a combination of this atypical
antipsychotic and lithium), and the extent to which the
patient adheres to this treatment, may largely influence
whether this patient will develop a manic episode and
subsequently be diagnosed with bipolar I disorder.
Although bipolar I and bipolar II disorders are reported
to differ in clinical correlates such as age of onset or
course of illness (Angst et al. 2010; Merikangas et al.
2007), these findings may be less valid in the future. Withhis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
Table 1 Minimum requirements for diagnosis of selected bipolar subtypes in DSM-5
Subtype At least one
full manic
episode









Bipolar I disorder Yes No No No
Bipolar II disorder No Yes Yes No
Short-duration hypomanic episodes (2 to 3 days) and major
depressive episodes (other specified bipolar and related disorders)
No Yes No Yes (2 episodes of short-
duration hypomania)
Hypomanic episodes with insufficient symptoms and major
depressive episodes (other specified bipolar and related disorders)
No Yes No Yes
Severus and Bauer International Journal of Bipolar Disorders 2014, 2:3 Page 2 of 2
http://www.journalbipolardisorders.com/content/2/1/3the expansion of the diagnostic criteria, a diagnosis of
bipolar I disorder may be more related to treatment
decisions for subthreshold bipolar II states rather than
to differences in pathophysiology. In this context, the
current emphasis on further delineating subtypes of
bipolar disorders may be questioned. We suggest there
is a need to better differentiate subthreshold hypomanic
episodes from similar symptoms that occur in differential
diagnoses such as normal mood swings, ADHD, nar-
cissistic personality disorder, or borderline personality
disorder (Kernberg and Yeomans 2013; Zimmerman
et al. 2013). For example, in a patient presenting with a
major depressive episode, probing for past ‘hyper or
wired’ states with a discernible beginning and end, and
including information provided by significant others,
may be of help. In case of doubt, we recommend waiting
until the patient has remitted and again experiences a
‘hyper or wired’ state rather than starting treatment
for bipolar disorders. At this point, the patient should
be reassessed by the psychiatrist and a more definite
diagnosis made.
We also suggest there is an immediate need for research
to more accurately capture the very essence of prototypic
subthreshold hypomanic episodes. This includes prospect-
ively and objectively measuring behavioral variables
associated with subthreshold and hypomanic episodes
such as communication patterns, speech, or range of
motion. Projects should include the use of innovative
ambulatory monitoring with wearable technologies or
smartphones (Ebner-Priemer and Trull 2009; Trull and
Ebner-Priemer 2013; Faurholt-Jepsen et al. 2013), in
conjunction with self-ratings, and prospective clinical
assessments. Better understanding of the longitudinal
course of all bipolar disorder subtypes included in the
DSM-5 is needed.
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